Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple, diffuse schwannomas in a RASopathy phenotype patient with germline KRAS mutation: a causal relationship?

Clinical genetics - 1 Jun 2012

Bertola D R, Pereira A C, Brasil A C, Suzuki L, Leite C, Falzoni R, Tannuri U, Poplawski A B, Janowski K M, Kim C A, Messiaen L M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomal Proteins, Non-Histone
Share to Germ-Line Mutation
Share to Neurilemmoma
Share to Neurofibromin 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to SMARCB1 Protein

Source

Identifiers

PMID: 22211815
DOI: 10.1111/j.1399-0004.2011.01764.x

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple, diffuse schwannomas in a RASopathy phenotype patient with germline KRAS mutation: a causal relationship?PMID 22211815Read ↗

Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteriaSemantic proximity Read ↗

Mosaic RASopathy due to KRAS variant G12D with segmental overgrowth and associated peripheral vascular malformations.Semantic proximity Read ↗

RASopathies: From germline mutations to somatic and multigenic diseases.Semantic proximity Read ↗

Localized Hypertrophic Neuropathy as a Neoplastic Manifestation of KRAS-Mediated RASopathy.Semantic proximity Read ↗

Oncogenic MAPK pathway activation disrupts Schwann cell fate commitment, inducing congenital and progressive neuropathy in miceSemantic proximity Read ↗

The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.Semantic proximity Read ↗

Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.Semantic proximity Read ↗

Schwannomas and Their PathogenesisSemantic proximity Read ↗

Mosaic KRAS mutations cause an atypical variant of phacomatosis spilosebacea.Semantic proximity Read ↗

NRAS associated RASopathy and embryonal rhabdomyosarcoma.Semantic proximity Read ↗

Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutation.Semantic proximity Read ↗

Melanoma arising in a giant congenital melanocytic nevus with neuroblastoma RAS mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.